Clinical Trials Browser

Phase 1 × Terminated × Advanced Refractory Solid Tumors × Clear all

NCT03195764 2022-11-18

Safety and Tolerability Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Advanced Refractory Solid Tumors